Orbimed Advisors - STRONGBRIDGE BIOPHARMA PLC ownership

STRONGBRIDGE BIOPHARMA PLC's ticker is SBBP and the CUSIP is G85347105. A total of 75 filers reported holding STRONGBRIDGE BIOPHARMA PLC in Q1 2021. The put-call ratio across all filers is 1.38 and the average weighting 0.2%.

Quarter-by-quarter ownership
Orbimed Advisors ownership history of STRONGBRIDGE BIOPHARMA PLC
ValueSharesWeighting
Q3 2021$1,621,000
-68.7%
794,675
-54.5%
0.02%
-65.4%
Q2 2021$5,182,000
+7.6%
1,744,6690.0%0.05%
+15.6%
Q1 2021$4,815,000
-43.2%
1,744,669
-50.0%
0.04%
-39.2%
Q4 2020$8,479,000
+15.7%
3,489,3690.0%0.07%
-19.6%
Q3 2020$7,328,0003,489,3690.09%
Other shareholders
STRONGBRIDGE BIOPHARMA PLC shareholders Q1 2021
NameSharesValueWeighting ↓
CAXTON CORP 5,376,039$47,309,00051.34%
Lyon Street Capital, LLC 3,182,149$28,162,0009.07%
Opaleye Management Inc. 1,590,000$14,071,0004.02%
Broadfin Capital, LLC 2,793,752$24,725,0003.85%
Vivo Capital, LLC 1,918,132$16,975,0002.40%
ARMISTICE CAPITAL, LLC 3,372,000$29,842,0002.28%
PRECEPT MANAGEMENT LLC 470,000$4,160,0001.73%
NEA Management Company, LLC 4,141,308$36,651,0001.63%
Harvest Capital Strategies LLC 825,000$7,301,0001.14%
Granite Point Capital Management, L.P. 567,895$5,026,0000.49%
View complete list of STRONGBRIDGE BIOPHARMA PLC shareholders